Munich - Delayed Quote • EUR OKYO Pharma Ltd (OK11.MU) Follow Compare 1.0600 0.0000 (0.00%) As of 8:08:54 AM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for OK11.MU 1D 5D 0.00% 1M -1.85% 6M -20.30% YTD -33.53% 1Y -36.38% 5Y -44.21% All -44.21% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: OK11.MU View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Begins Key Phase 2 Trial for Eye Pain Drug OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain OKYO Pharma Announces Chairman Acquires Shares OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV OKYO Pharma CEO Interview to Air on Bloomberg TV OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference Related Tickers FOLD Amicus Therapeutics, Inc. 9.89 -0.10% ALEC Alector, Inc. 1.8900 -4.55% AKRO Akero Therapeutics, Inc. 30.61 +4.72% APVO Aptevo Therapeutics Inc. 4.2000 +8.25% UNCY Unicycive Therapeutics, Inc. 0.6995 -0.07% MRNA Moderna, Inc. 40.76 -2.58%